AKAM
59
-3
AMP
69
3
CMA
70
2
ALL
57
-7
CRM
57
7
CCL
55
-2
DAL
74
-2
CF
48
3
ABBV
57
-2
BAX
42
-5
ADP
61
-3
AON
60
4
CPB
37
-2
COST
48
-8
CCI
36
2
VIX
40
2
CTAS
28
-3
AES
57
13
CAG
34
-3
BK
74
3
AKAM
59
-3
AMP
69
3
CMA
70
2
ALL
57
-7
CRM
57
7
CCL
55
-2
DAL
74
-2
CF
48
3
ABBV
57
-2
BAX
42
-5
ADP
61
-3
AON
60
4
CPB
37
-2
COST
48
-8
CCI
36
2
VIX
40
2
CTAS
28
-3
AES
57
13
CAG
34
-3
BK
74
3
Financhill
Back

iShares Biotechnology ETF Stock Predictions

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61

IBB
iShares Biotechnology ETF

Last Price:
$172.08
Seasonality Move:
1.51%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

iShares Biotechnology ETF Stock Forecast

  • Over the next 52 weeks, iShares Biotechnology ETF has on average historically risen by 9.6% based on the past 24 years of stock performance.
  • iShares Biotechnology ETF has risen higher in 19 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.17%
  • Is iShares Biotechnology ETF Stock Undervalued?
    The current iShares Biotechnology ETF [IBB] share price is $172.11. The Score for IBB is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • IBB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will iShares Biotechnology ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares Biotechnology ETF has on average historically risen by 9.6% based on the past 24 years of stock performance.

iShares Biotechnology ETF Stock Rating

Buy
61
iShares Biotechnology ETF (IBB) is a Buy

Is iShares Biotechnology ETF overpriced?

  • iShares Biotechnology ETF has risen higher in 19 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.17%

iShares Biotechnology ETF Stock Price History

Is IBB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
174.40
52-Week Low:
107.43

Prediction Charts

Market Cap:
0
Price in USD:
172.11
Volume:
1.7M
Beta:
0.90

Technical Analysis

SMA50:
158.10
SMA100:
147.71
SMA200:
137.30
52-Wk Change:
20.18%

Stock Predictions

  • Is iShares Biotechnology ETF stock public?
    Yes, iShares Biotechnology ETF is a publicly traded company.
  • What is the iShares Biotechnology ETF stock quote today?
    The iShares Biotechnology ETF stock price is 172.11 USD today.
  • How to buy iShares Biotechnology ETF stock online?
    You can buy iShares Biotechnology ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 162.03 164.19 165.96 161.66
Nov-17 164.11 165.26 167.15 163.39
Nov-18 164.76 166.47 167.14 163.78
Nov-19 166.05 165.22 166.77 164.39
Nov-20 166.81 164.24 168.50 164.11
Nov-21 164.38 167.52 168.73 164.05
Nov-24 167.84 169.71 170.28 167.84
Nov-25 170.57 172.33 172.41 170.07
Nov-26 172.55 173.66 174.23 172.14
Nov-28 174.14 173.83 174.40 172.84
Dec-1 172.55 170.11 172.69 169.90
Dec-2 170.16 169.22 171.02 168.79
Dec-3 169.59 172.23 172.45 169.55
Dec-4 172.14 172.11 172.81 170.10

iShares Biotechnology ETF Earnings

Data Unavailable

iShares Biotechnology ETF Forecast Revenue Growth

Data Unavailable

* iShares Biotechnology ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.